PCRX
Pacira BioSciences, Inc.
NASDAQ: PCRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$22.74
-1.77% today
Updated 2026-05-11
Market cap
$910.90M
P/E ratio
178.08
P/S ratio
1.24x
EPS (TTM)
$0.13
Dividend yield
—
52W range
$19 – $28
Volume
0.7M
Pacira BioSciences, Inc. (PCRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.93M | $15.01M | $14.56M | $15.69M | $39.08M | $85.55M | $197.67M | $249.00M | $276.37M | $286.63M | $337.28M | $421.03M | $429.65M | $541.53M | $666.82M | $674.98M | $700.97M | $726.41M |
| Revenue growth (YoY) | — | +7.8% | -3.0% | +7.7% | +149.1% | +118.9% | +131.1% | +26.0% | +11.0% | +3.7% | +17.7% | +24.8% | +2.0% | +26.0% | +23.1% | +1.2% | +3.9% | +3.6% |
| Cost of revenue | $17.46M | $12.30M | $12.28M | $16.74M | $32.14M | $54.77M | $77.44M | $71.84M | $110.10M | $87.92M | $86.84M | $106.71M | $117.33M | $140.25M | $199.29M | $184.67M | $170.43M | $149.75M |
| Gross profit | $-3.54M | $2.71M | $2.29M | $-1.05M | $6.95M | $30.78M | $120.23M | $177.16M | $166.27M | $198.72M | $250.43M | $314.31M | $312.32M | $401.28M | $467.53M | $490.31M | $530.54M | $576.66M |
| Gross margin | -25.4% | 18.0% | 15.7% | -6.7% | 17.8% | 36.0% | 60.8% | 71.1% | 60.2% | 69.3% | 74.3% | 74.7% | 72.7% | 74.1% | 70.1% | 72.6% | 75.7% | 79.4% |
| R&D | $33.21M | $26.23M | $18.63M | $14.87M | $9.94M | $21.56M | $18.73M | $28.66M | $45.68M | $57.29M | $55.69M | $72.12M | $59.42M | $55.55M | $84.80M | $76.26M | $81.58M | $117.31M |
| SG&A | $41.83M | $31.25M | $24.66M | $20.16M | $15.97M | $20.96M | $41.65M | $61.31M | $63.40M | $66.69M | $70.16M | $71.12M | $74.83M | $88.32M | $109.52M | $116.40M | $122.08M | $142.14M |
| Operating income | $-45.36M | $-28.55M | $-22.37M | $-39.10M | $-49.30M | $-53.29M | $-5.17M | $9.46M | $-32.02M | $-24.94M | $15.91M | $10.48M | $46.35M | $89.92M | $60.02M | $87.67M | $-73.37M | $33.30M |
| Operating margin | -325.8% | -190.2% | -153.6% | -249.2% | -126.1% | -62.3% | -2.6% | 3.8% | -11.6% | -8.7% | 4.7% | 2.5% | 10.8% | 16.6% | 9.0% | 13.0% | -10.5% | 4.6% |
| EBITDA | $-41.53M | $-24.12M | $-19.12M | $-34.23M | $-44.55M | $-50.73M | $5.09M | $21.39M | $-17.86M | $-10.59M | $33.05M | $30.75M | $63.51M | $113.95M | $140.38M | $154.59M | $29.12M | $122.50M |
| EBITDA margin | -298.3% | -160.7% | -131.3% | -218.2% | -114.0% | -59.3% | 2.6% | 8.6% | -6.5% | -3.7% | 9.8% | 7.3% | 14.8% | 21.0% | 21.1% | 22.9% | 4.2% | 16.9% |
| EBIT | $-45.36M | $-28.55M | $-23.37M | $-38.55M | $-50.20M | $-56.48M | $-4.94M | $9.92M | $-30.78M | $-24.42M | $19.89M | $11.17M | $43.60M | $85.40M | $48.88M | $79.01M | $-49.67M | $31.48M |
| Interest expense | $3.49M | $3.60M | $4.89M | $4.78M | $1.81M | $7.25M | $8.28M | $7.72M | $7.06M | $18.05M | $21.95M | $23.63M | $25.67M | $29.00M | $35.58M | $17.31M | $16.57M | $14.61M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-41.86M | $-31.71M | $-27.15M | $-43.33M | $-52.28M | $-63.91M | $-13.72M | $1.86M | $-37.95M | $-42.61M | $-471000.00 | $-11.02M | $145.52M | $41.98M | $15.91M | $41.95M | $-99.56M | $7.03M |
| Net income growth (YoY) | — | +24.3% | +14.4% | -59.6% | -20.7% | -22.2% | +78.5% | +113.5% | -2144.7% | -12.3% | +98.9% | -2238.9% | +1421.0% | -71.2% | -62.1% | +163.7% | -337.3% | +107.1% |
| Profit margin | -300.6% | -211.3% | -186.4% | -276.2% | -133.8% | -74.7% | -6.9% | 0.7% | -13.7% | -14.9% | -0.1% | -2.6% | 33.9% | 7.8% | 2.4% | 6.2% | -14.2% | 1.0% |